JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Orthofix International NV

Slēgts

SektorsVeselības aprūpe

12.33 1.82

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.31

Max

12.42

Galvenie mērījumi

By Trading Economics

Ienākumi

-97M

-120M

Pārdošana

14M

220M

Peļņas marža

-54.69

Darbinieki

1,605

EBITDA

95M

92M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+48.42% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 5. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-30M

508M

Iepriekšējā atvēršanas cena

10.51

Iepriekšējā slēgšanas cena

12.33

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bearish Evidence

Orthofix International NV Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. apr. 19:19 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Group Rejects EQT's Revised Offer

2026. g. 24. apr. 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Scoring the Cook Era -- Barrons.com

2026. g. 24. apr. 20:51 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 24. apr. 20:39 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 20:09 UTC

Peļņas

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026. g. 24. apr. 19:48 UTC

Tirgus saruna
Galvenie ziņu notikumi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 19:25 UTC

Iegādes, apvienošanās, pārņemšana

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026. g. 24. apr. 19:22 UTC

Peļņas

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026. g. 24. apr. 19:06 UTC

Peļņas

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026. g. 24. apr. 19:05 UTC

Tirgus saruna

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026. g. 24. apr. 18:30 UTC

Iegādes, apvienošanās, pārņemšana

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026. g. 24. apr. 18:28 UTC

Iegādes, apvienošanās, pārņemšana

Intertek Rejects Revised EQT Offer

2026. g. 24. apr. 18:12 UTC

Tirgus saruna

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026. g. 24. apr. 18:06 UTC

Tirgus saruna

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026. g. 24. apr. 17:42 UTC

Peļņas

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Peļņas

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

2026. g. 24. apr. 17:28 UTC

Tirgus saruna

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

2026. g. 24. apr. 17:12 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 24. apr. 17:11 UTC

Tirgus saruna

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

2026. g. 24. apr. 17:09 UTC

Tirgus saruna
Peļņas

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

2026. g. 24. apr. 17:09 UTC

Iegādes, apvienošanās, pārņemšana

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026. g. 24. apr. 17:06 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

2026. g. 24. apr. 16:51 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 24. apr. 16:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 24. apr. 16:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

Orthofix International NV Prognoze

Cenas mērķis

By TipRanks

48.42% augšup

Prognoze 12 mēnešiem

Vidējais 18.33 USD  48.42%

Augstākais 20 USD

Zemākais 17 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Orthofix International NV — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

3

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

10.4 / 12.1Atbalsts un pretestība

Īstermiņā

Weak Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Orthofix International NV

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
help-icon Live chat